Rebecca Lee

ORCID: 0000-0003-2540-2009
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer Genomics and Diagnostics
  • CAR-T cell therapy research
  • Melanoma and MAPK Pathways
  • Cutaneous Melanoma Detection and Management
  • COVID-19 and healthcare impacts
  • Cancer Immunotherapy and Biomarkers
  • Legal principles and applications
  • Immunotherapy and Immune Responses
  • Cancer Cells and Metastasis
  • COVID-19 Clinical Research Studies
  • Blood Pressure and Hypertension Studies
  • Heart Rate Variability and Autonomic Control
  • Childhood Cancer Survivors' Quality of Life
  • Adolescent and Pediatric Healthcare
  • Lymphoma Diagnosis and Treatment
  • Chronic Lymphocytic Leukemia Research
  • Mast cells and histamine
  • Schizophrenia research and treatment
  • Healthcare cost, quality, practices
  • Corporate Governance and Law
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Colorectal Cancer Treatments and Studies
  • Receptor Mechanisms and Signaling
  • Diversity and Career in Medicine
  • Health Policy Implementation Science

The Christie NHS Foundation Trust
2013-2025

University of Manchester
2015-2025

Natural Resources Canada
2023-2025

Keck Hospital of USC
2025

University of Southern California
2017-2025

Geological Survey of Canada
2024-2025

Baylor University Medical Center
2024-2025

Cancer Research UK Manchester Institute
2015-2024

Centre for Mental Health
2024

The University of Melbourne
2024

Folic acid was covalently conjugated to 66-nm liposomes via spacers of various lengths in an attempt target the KB cells expressing folate receptors. Spacers short and intermediate were unable mediate association folate-conjugated with receptor-bearing cells, however, use a 250 A polyethyleneglycol spacer (PEG, M(r) approximately 3350) permitted avid uptake at 2.5 x 10(5) sites/cell. The binding folate-PEG could be competitively inhibited by excess free or antiserum against receptor,...

10.1016/s0021-9258(17)41848-5 article EN cc-by Journal of Biological Chemistry 1994-02-01
Lennard Y. W. Lee Jean‐Baptiste Cazier Thomas Starkey Sarah Briggs Roland Arnold and 95 more Vartika Bisht Stephen Booth Naomi Campton Vinton W.T. Cheng Graham P. Collins Helen Curley Philip Earwaker Matthew W. Fittall Spyridon Gennatas Anshita Goel Simon Hartley D.J. Hughes David Kerr Alvin Lee Rebecca Lee SM Lee Hayley McKenzie Chris P Middleton Nirupa Murugaesu Tom Newsom‐Davis Anna Olsson‐Brown Claire Palles Thomas Powles Emily Protheroe Karin Purshouse Archana Sharma‐Oates Shivan Sivakumar Ashley J. Smith Oliver Topping Chris D. Turnbull Csilla Várnai Adam Briggs Gary Middleton Rachel Kerr Abigail Gault Michael Agnieszka Ahmed Bedair Aisha Ghaus Akinfemi Akingboye Alec Maynard Alexander Pawsey Ali Abdulnabi Suwaidan Alicia Okines Alison Massey Amy Kwan Ana Ferreira Angelos Angelakas Anjui Wu Ann Tivey Anne Armstrong Annet Madhan Annet Pillai Ashley Poon-King Bartlomiej Kurec Caroline Usborne Caroline Dobeson Christina Thirlwell Christian D. Mitchell Christopher C.T. Sng Christopher Scrase Jingree Christopher Clair Brunner Claire Fuller Clare Griffin Craig Barrington Daniel J. Müller Diego Ottaviani Duncan C. Gilbert Eliana MC Tacconi Ellen Copson Emily Renninson Emma Cattell Emma Burke Fiona Smith Francesca Holt Gehan Soosaipillai Hayley Boyce Heather Shaw Helen Hollis Helen Bowyer Iris Anil Jack Illingworth Jack Gibson Jaishree Bhosle James Best Jane Barrett Jillian Noble Joseph J. Sacco Joseph Chacko Julia Chackathayil Kathryn Banfill Laura Feeney Laura Horsley L. Cammaert Leena Mukherjee

10.1016/s1470-2045(20)30442-3 article EN The Lancet Oncology 2020-08-24
Thomas Beaney Louise M. Burrell Rafael R. Castillo Fadi J. Charchar Suzie Cro and 95 more Albertino Damasceno Ruan Kruger Peter M Nilsson Dorairaj Prabhakaran Agustín J. Ramiréz Markus P. Schlaich Aletta E. Schutte Maciej Tomaszewski Rhian M. Touyz Ji-Guang Wang Michael A. Weber Neil R Poulter Genc Burazeri Gentiana Qirjako Enver Roshi Rudina Cunashi Mario J C C Fernandes Savarino S Victória Pereira Marisa F M P Neto Pombalino N M Oliveira Ana C G Feijão Yamila Cerniello Marcos J. Marín Fortunato García Vásquez Walter G. Espeche Diego Stisman Inés A Fuentes Juith M Zilberman P. Rodríguez Carnero Kamsar Yu Babinyan Anna H Engibaryan Avag Avagyan Arsen Minasyan A. Gevorkyan Revathy Carnagarin M. Carrington James E. Sharman Rebecca Lee Sabine Perl Ella Niederl Fazila‐Tun‐Nesa Malik Sohel Reza Choudhury Mohammad Al Mamun Mir Ishraquzzaman Fiona Anthony Kenneth Connell Tine De Backer Jea Krzesinski Martin Houénassi Corine Houéhanou Dragan Lović Rankica Bahtijarevic Mary Banyana Tiro Mosepele Mosepele Tiny Masupe Weimar Kunz Sebba Barroso Marco Antônio Mota Gomes Audes D. M. Feitosa Andréa Araújo Brandão Roberto Dischinger Miranda Vanda Azevedo Luis M Dias Glenda Garcia Idiana P P Martins Anastase Dzudié Samuel Kingué F Djomou Epie Njume Nadia Khan Fernando Laņas María Soledad Fernández García Mélanie Paccot Pamela Torres Yan Li Min Liu Liying Xu Li Li Xin Chen Junping Deng Wenwu Zhao Lingjuan Fu Yi Zhou Patricio López‐Jaramillo Johanna Otero Paul Anthony Camacho José Accini Gregorio Sánchez Édgar Arcos Jean-René M’Buyamba-Kabangu Fortunat K Katamba Georges N Ngoyi Nathan M Buila Pascal Bayauli Bertrand Fikahem Ellenga Mbolla Paterne R Bakekolo

Raised blood pressure (BP) is the biggest contributor to mortality and disease burden worldwide fewer than half of those with hypertension are aware it. May Measurement Month (MMM) a global campaign set up in 2017, raise awareness high BP as pragmatic solution lack formal screening worldwide. The 2018 was expanded, aiming include more participants countries.

10.1093/eurheartj/ehz300 article EN cc-by-nc European Heart Journal 2019-04-25

Targeted therapies and immunotherapies have transformed melanoma care, extending median survival from ∼9 to over 25 months, but nevertheless most patients still die of their disease. The aim precision medicine is tailor care for individual improve outcomes. To this end, we developed protocols facilitate individualized treatment decisions with advanced melanoma, analyzing 364 samples 214 patients. Whole exome sequencing (WES) targeted circulating tumor DNA (ctDNA) allowed us monitor responses...

10.1158/2159-8290.cd-15-1336 article EN Cancer Discovery 2015-12-30

The advent of effective adjuvant therapies for patients with resected melanoma has highlighted the need to stratify based on risk relapse given cost and toxicities associated treatment. Here we assessed circulating tumor DNA (ctDNA) predict monitor in stage III melanoma.

10.1093/annonc/mdz048 article EN publisher-specific-oa Annals of Oncology 2019-02-05

This paper contributes with a pragmatic evaluation framework for explainable Machine Learning (ML) models clinical decision support. The study revealed more nuanced role ML explanation models, when these are pragmatically embedded in the context. Despite general positive attitude of healthcare professionals (HCPs) towards explanations as safety and trust mechanism, significant set participants there were negative effects associated confirmation bias, accentuating model over-reliance...

10.1016/j.artint.2022.103839 article EN cc-by Artificial Intelligence 2022-12-20

Recent sham-controlled randomized clinical trials have confirmed the safety and efficacy of catheter-based renal denervation (RDN). Long-term data beyond 3 years are scarce. Here, we report on outcomes after RDN in a cohort patients with resistant hypertension an average ≈9-year follow-up (FU).We recruited who were previously enrolled various applying radiofrequency energy for blood pressure (BP) lowering. All participants had baseline assessments before repeat assessment at long-term FU...

10.1161/hypertensionaha.122.20853 article EN Hypertension 2023-02-10

Abstract Caldesmon is a smooth muscle and nonmuscle regulatory protein that interacts with actin, myosin, tropomyosin, calmodulin. Two overlapping clones, isolated from chicken oviduct cDNA plasmid library gizzard lambda NM1149 library, were used to generate 4108-base pair sequence coding for one caldesmon. Expression of the confirms this large caldesmons. The deduced molecular weight 86.974, significantly less than weights estimated by sodium dodecyl sulfate gel electrophoresis. has high...

10.1016/s0021-9258(18)80081-3 article EN cc-by Journal of Biological Chemistry 1989-08-01

Abstract It would be much easier to assess the effectiveness of different reintroduction methods, and so improve success reintroductions, if there was greater standardization in documentation methods outcomes. We suggest a series standards for documenting monitoring outcomes associated with projects birds. Key suggestions are: planned release before it occurs, specifying information required on each release, postrelease occurring at standard intervals 1 5 years (and 10 long‐lived species),...

10.1111/j.1755-263x.2010.00113.x article EN other-oa Conservation Letters 2010-03-29

IntroductionTumour burden is a prognostic biomarker in metastatic melanoma. However, tumour difficult to measure and there are currently no reliable surrogate biomarkers easily reliably determine it. The aim of this study was assess the potential plasma total cell free DNA as prognosis melanoma patients.Materials methodsA prospective cohort for circulating cell-free (cfDNA) concentration performed 43 patients. For 38 patients, paired blood collections scan assessments were available before...

10.1016/j.ejca.2017.10.029 article EN cc-by European Journal of Cancer 2017-11-24

Patients with high-risk stage II/III resected melanoma commonly develop distant metastases. At present, we cannot differentiate between patients who will recur or those are cured by surgery. We investigated if circulating tumor DNA (ctDNA) can predict relapse and survival in melanoma.

10.1093/annonc/mdx717 article EN cc-by Annals of Oncology 2017-11-02

Despite substantial clinical benefit of targeted and immune checkpoint blockade-based therapies in melanoma, resistance inevitably develops. We show cytoskeletal remodeling changes expression activity ROCK-myosin II pathway during acquisition to MAPK inhibitors. regulates myosin activity, but after initial therapy response, drug-resistant clones restore increase survival. High correlates with aggressiveness, identifying therapy- immunotherapy-resistant melanomas. Survival resistant cells is...

10.1016/j.ccell.2019.12.003 article EN cc-by Cancer Cell 2020-01-01

Background Aedes albopictus is an important dengue vector because of its aggressive biting behavior and rapid spread out native home range in Southeast Asia. Pyrethroids are widely used for adult mosquito control, resistance to pyrethroids should be carefully monitored control the only effective method currently available prevent transmission. The voltage-gated sodium channel gene target site pyrethroids, mutations this cause knockdown (kdr). Previous studies reported various (VGSC) gene,...

10.1371/journal.pntd.0004696 article EN cc-by PLoS neglected tropical diseases 2016-05-04

Autophagosome formation depends on a carefully orchestrated interplay between membrane-associated protein complexes. Initiation of macroautophagy/autophagy is mediated by the ULK1 (unc-51 like autophagy activating kinase 1) complex and autophagy-specific class III phosphatidylinositol 3-kinase I (PtdIns3K-C1). The latter contains PIK3C3/VPS34, PIK3R4/VPS15, BECN1/Beclin 1 ATG14 phosphorylates to generate 3-phosphate (PtdIns3P). Here, we show that PIK3C3, BECN1 contain functional LIR motifs...

10.1080/15548627.2019.1581009 article EN cc-by Autophagy 2019-02-15

The cysteine protease ATG4B cleaves off one or more C-terminal residues of the inactive proform proteins ortholog and paralog LC3 GABARAP subfamilies yeast Atg8 to expose a glycine that is conjugated phosphatidylethanolamine during autophagosome formation. We show contains LC3-interacting region (LIR) motif important for efficient binding cleavage proteins. solved crystal structures GABARAPL1-ATG4B LIR complex. Analyses in vitro assays, using specific point mutants, clearly showed binds via...

10.1080/15548627.2017.1287651 article EN Autophagy 2017-02-15

Abstract Whole-brain radiotherapy (WBRT) is the treatment backbone for many patients with brain metastasis; however, its efficacy in preventing disease progression and associated toxicity have questioned clinical impact of this approach emphasized need alternative treatments. Given limited therapeutic options available these poor understanding molecular mechanisms underlying resistance metastatic lesions to WBRT, we sought uncover actionable targets biomarkers that could help refine patient...

10.1038/s41591-022-01749-8 article EN cc-by Nature Medicine 2022-04-01
Csilla Várnai Claire Palles Roland Arnold Helen Curley Karin Purshouse and 95 more Vinton W.T. Cheng Stephen Booth Naomi Campton Graham P. Collins D.J. Hughes Austin Kulasekararaj Alvin Lee Anna Olsson‐Brown Archana Sharma‐Oates Mieke Van Hemelrijck Lennard Y. W. Lee Rachel Kerr Gary Middleton Jean‐Baptiste Cazier S. Pugh Pippa Corrie Ahmed Bedair Madeleine Hewish Pauline Leonard Jack Illingworth Stephen Hibbs Nicolaos Diamantis Samah Massalha Claire Fuller Caroline Usbourne Duncan C. Gilbert Jennifer Davies Tom Newsom‐Davis Rachel Sharkey Rebecca Lee Ann Tivey Rohan Shotton Clare Griffin Laura Horsley Simon Shamas Joseph J. Sacco Madbuba Choudhury Jillian Noble Heather Shaw Rachel Bolton Ana Ferreira Peter Hall Paul Ramage Jaishree Bhosle Alison Massey Michaela Hill Leena Mukherjee Aisha Ghaus Sarah Derby Sean Brown Sarah Lowndes Saorise Dolly Beth Russell Charlotte Moss Daniel J. Müller Annet Pillai Shakeel Lowe Lucy Cook Christopher Scrase R. Jyothirmayi Ruth Board Stephanie Cornthwaite Shefail Parikh Emma Cattell Nicola Cox Abigail Gault Sam Moody Caroline Dobeson Mark Baxter Tom Roques Alexander Pawsey Roderick Oakes Lucinda Melcher Olivia Chan Sarah Ayers Helen Bowyer Mohammed Althohami Sajjan Mittal Laura Feeney Avinash Aujayeb Omar Sheikh Sangary Kathirgamakarthigeyan Victoria K. Woodcock Francesca Holt Simon Wyatt Oliver Topping Michaël Tilby Madhumita Bhattacharyya Emma Burke Shawn Ellis Joseph Chacko Taslima Rabbi Michael Rowe Rebecca Sargent Christina Thirlwell

Large cohorts of patients with active cancers and COVID-19 infection are needed to provide evidence the association recent cancer treatment type mortality.

10.1001/jamanetworkopen.2022.0130 article EN cc-by-nc-nd JAMA Network Open 2022-02-21

Overactivation of renal sympathetic nervous system and low-grade systemic inflammation are common features hypertension. Renal denervation (RDN) reduces activity in patients with resistant However, its effect on has not been examined. We prospectively investigated the RDN monocyte activation uncontrolled hypertension scheduled for RDN. Ambulatory blood pressure, monocyte, subset inflammatory markers were assessed at baseline, 3 months, 6 months after procedure 42 patients. significantly...

10.1161/hypertensionaha.116.08373 article EN Hypertension 2016-12-13

Abstract The therapeutic potential of administering stem cells to promote angiogenesis and myocardial tissue regeneration after infarction has recently been demonstrated. Given the advantages using embryonic mouse models for furthering development this approach, purpose study was determine if could be loaded with superparamagnetic iron oxide (SPIO) particles imaged in a model over time MRI. Mouse were labeled SPIO particles. When incubated 11.2, 22.4, 44.8 μg Fe/ml particles, took up...

10.1002/mrm.20220 article EN Magnetic Resonance in Medicine 2004-10-26
Coming Soon ...